Analysts at RBC Capital hosted investor meetings with IDEX Corporation (NYSE:IEX) CFO in NYC on June 9. Consistent with the Q1/22 update, the company continues to see mostly healthy demand across its businesses, with growth notionally slowing because of tougher comps. Earnings visibility remains high, with backlog 2x typical levels, essentially providing line-of-sight to the full quarter of revenues vs. the typical half-backlog/half-book-and-ship mix.

Supply chain conditions remain challenging but have not worsened. The analysts expect to see more investor interest in the company as it offers both cyclical exposures and the high-quality appeal of a proven multi-Industry compounder.